Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

NCT00848783 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual

Conditions

Gastric Cancer
Gastric Adenocarcinoma
Esophageal Cancer

Interventions

DRUG: Irinotecan
DRUG: Cisplatin
PROCEDURE: Surgery
DRUG: Floxuridine
DRUG: Capecitabine

Sponsor

NYU Langone Health